Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 852 Neoplasms 643 Prostatic Neoplasms 439 Lung Neoplasms 359 Colorectal Neoplasms 327 Carcinoma, Non-Small-Cell Lung 318 Leukemia, Myeloid, Acute 251 Pancreatic Neoplasms 218 Brain Neoplasms 202 Multiple Myeloma 198 Neoplasm Metastasis 191 Carcinoma, Hepatocellular 178 Head and Neck Neoplasms 176 Glioblastoma 167 Precursor Cell Lymphoblastic Leukemia-Lymphoma 166 Melanoma 153 Ovarian Neoplasms 149 Squamous Cell Carcinoma of Head and Neck 148 Rectal Neoplasms 134 Recurrence 132 Hematologic Neoplasms 125 Sarcoma 124 Uterine Cervical Neoplasms 117 Stomach Neoplasms 116 Carcinoma, Renal Cell 115 Triple Negative Breast Neoplasms 114 Glioma 114 Motor Activity 100 Myelodysplastic Syndromes 96 Esophageal Neoplasms 96

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Cerebrospinal Fluid Rhinorrhea × 90 days × Clear all

NCT07539792 2026-04-20

EEEA-AMSBP

Nanfang Hospital, Southern Medical University

Phase 2 Recruiting

Cerebrospinal Fluid Rhinorrhea

Data powered by HemOnc (CC BY 4.0) Colophon ⚡